Resources
-
Technical Seminar Presented by KBI Biopharma, Inc., 2026
Speaker Presentation: WCBP 2026
Technical Seminar Presented by KBI Biopharma, Inc., 2026 -
Technical Seminar Presented by Cygnus Technologies, LLC, 2026
Speaker Presentation: WCBP 2026
Technical Seminar Presented by Cygnus Technologies, LLC, 2026 -
Technical Seminar Presented by Clear Solutions Laboratories AG, 2026
Speaker Presentation: WCBP 2026
Technical Seminar Presented by Clear Solutions Laboratories AG, 2026 -
Technical Seminar Presented by Catalent, Inc., 2026
Speaker Presentation: WCBP 2026
Technical Seminar Presented by Catalent, Inc., 2026 -
Mini Case Studies Session 2 - Cloud-Based Platforms for Regulatory Submissions: Project PRISM and Accumulus CMC Use Cases
Speaker Presentation: WCBP 2026
Mini Case Studies Session 2 - Cloud-Based Platforms for Regulatory Submissions: Project PRISM and Accumulus CMC Use Cases -
Mini Case Session 1 - Case Studies of Characterization of Minor Degradation Products from High Performance Liquid Chromatography (HPLC) or Capillary Electrophoresis (CE) Methods
Speaker Presentation: WCBP 2026
Mini Case Session 1 - Case Studies of Characterization of Minor Degradation Products from High Performance Liquid Chromatography(HPLC) or Capillary Electrophoresis (CE) Methods -
Mini Case Session 1 - Advances in Process Analytics and Real Time Release Testing (RTRT)
Speaker Presentation: WCBP 2026
Mini Case Session 1 - Advances in Process Analytics and Real Time Release Testing (RTRT) -
From Construction to End-to-End Drug Substance and Drug Product GMP Manufacturing of mRNA Vaccines in Africa: A Cross-Country Race to Epidemic/Pandemic Preparedness and Public Health Impact
Speaker Presentation: WCBP 2026
Terblanche Petro, Afrigen Biologics, 2026 -
Pivoting to Platform: A Case Study in Leveraging Reliance to Enable Fast Implementation of Platform Method for Commercial Products
Speaker Presentation: WCBP 2026
Wu Christine, Genentech, a Member of the Roche Group, 2026 -
Collaborative CMC Assessment of Post-Approval Change Management Protocols: A Regulatory Health Authority-Perspective
Speaker Presentation: WCBP 2026
Wilson Willie, CDER, FDA, 2026 -
Introduction to Session - AI in Development and Manufacturing – New Era in Well Characterized Biologics
Speaker Presentation: WCBP 2026
Thurau Gert, F. Hoffmann-La Roche Ltd., 2026 -
Predictive Stability for
Biopharmaceuticals & Vaccines:
Accelerating Patient Access through Industry
Recommendations and Stakeholder Alignment
Speaker Presentation: WCBP 2026
Skomski Daniel, Merck & Co., Inc., Ji Andrea, Genentech, a Member of the Roche Group, 2026 -
Keynote Speaker - Michael Sheahan, Danforth, Health, Inc.
Speaker Presentation: WCBP 2026
Sheahan Michael, Danforth Health, Inc., 2026 -
Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Droplets in Biopharmaceutical Products
Speaker Presentation: WCBP 2026
Saggu Miguel, Genentech, a Member of the Roche Group, 2026 -
ICH Q1 Guideline Revisions: Risk Frameworks and Regulatory Readiness
Speaker Presentation: WCBP 2026
Russell Paula, Health Canada, 2026 -
Designing the AI-Enabled CMC Ecosystem for Drug Development and Manufacturing
Speaker Presentation: WCBP 2026
Rolandi Pablo, Amgen Inc., 2026 -
SAHPRA Support for Local GMP Manufacturing and Quality Testing
Speaker Presentation: WCBP 2026
Ratlabyana Mphako, South African Health Products Regulatory Authority (SAHPRA), 2026 -
What’s New in the World of Stability Testing?
Updates on ICH Q1/Q5C Revisions
Speaker Presentation: WCBP 2026
Rao Ashutosh, CDER, FDA, 2026 -
ICH M16 - Transitioning to Structured Product Quality Submissions
Speaker Presentation: WCBP 2026
Palacios Rodrigo, F. Hoffmann-La Roche Ltd., 2026 -
Enabling Global Pharmaceutical Innovation
Speaker Presentation: WCBP 2026
Nosal Roger, Vaxcyte, Inc., 2026